$ATNM
Actinium Pharmaceuticals, Inc
XASE•Health Care•Pharmaceutical Preparations
Actinium Pharmaceuticals, Inc
XASE•Health Care•Pharmaceutical Preparations
Why is ATNM down today? It is at $1.05 (-1.87%), and our scanner flagged it 21 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ATNM spikes, and full due diligence on ATNM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ATNM 21 times in the last 30 days. Create a free account to track $ATNM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ATNM traded in the last session, Friday (last price and move above). Our scanner fired 4 unusual-volume and momentum alerts on ATNM on Friday, peaking at 54.2x its normal volume.
Likely catalystActinium Pharmaceuticals, Inc.: Q3 FY2026 results, three months to Sep 30, 2025, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
David Matthew T Officer | Acquired (grant/award) | +250K 0.8% of company | n/a | 250K | n/a | Oct 14, 26 |
Chell Jeffrey W. Director | Acquired (grant/award) | +62K 0.2% of company | n/a | 62K | n/a | Sep 2, 26 |
Steinhart Richard I Director | Acquired (grant/award) | +63K 0.2% of company | added 100% | 63K | n/a | Sep 2, 26 |
Shetty Ajit Director | Acquired (grant/award) | +62K 0.2% of company | added 100% | 62K | n/a | Sep 2, 26 |
Seth Sandesh Officer | Acquired (grant/award) | +1.78M 5.7% of company | added 100% | 1.97M | n/a | Sep 2, 26 |
Nicholson, C. David Director | Acquired (grant/award) | +63K 0.2% of company | added 100% | 63K | n/a | Sep 2, 26 |
Almenoff June Sherie Director | Acquired (grant/award) | +18K 0.06% of company | n/a | 18K | n/a | Sep 2, 26 |
Seth Sandesh Officer | Sold (automatic/other) | -121K 0.4% of company | sold 40% | 184K | $207K at $1.71 | Aug 18, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how ATNM traded in the last session, Friday (last price and move above). Our scanner fired 4 unusual-volume and momentum alerts on ATNM on Friday, peaking at 54.2x its normal volume.
ATNM last traded at $1.05, down 1.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ATNM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ATNM 21 times in the last 30 days.
ATNM (Actinium Pharmaceuticals, Inc) trades on XASE, with a market cap of about $33M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ATNM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ATNM discussion
Sign in to ask a question or join the discussion.